Demand growing for Porvair Sciences' Chromatrap ChIP assay technology

Porvair Sciences reports strong growing demand for their Chromatrap® chromatin immunoprecipitation (ChIP) assay technology from academic groups and biopharmaceutical organisations involved with epigenetic research.

Stephen Knight, Sales and Marketing Director commented "An expanding number of proven application solutions and the introduction of the Chromatrap® 96 HT solid-state ChIP high throughput platform has enabled us to more than double the number of research groups using ChromaTrap assay technology during the last 12 months". He added "We are particularly pleased by the very positive feedback from early adopters of the technology".

Brian J. Engel, a Biochemistry & Cell Biology researcher at Rice University, USA commented "What I like most about the Chromatrap kit compared to traditional bead-based ChIP assays is the ease of use, speed and reliability. There is no worry about accidentally losing beads during washes and reducing output chromatin when using the column-based method". His colleague - Curt Warren added "We have found that the Chromatrap kit is quick, reliable and flexible. Saving reagents and time with this kit makes it easier and more feasible to conduct more thorough and effective IP based experiments. With the enhanced reproducibility using Chromatrap, I would not go back to bead-based ChIP and the assay has been fully endorsed and adopted within our research team".

Professor Steve Conlan, Head of Molecular & Cell Biology at Swansea University, UK commented "Chromatrap streamlines the complicated experimental procedure associated with chromatin-IP making it a much quicker and user-friendly assay compared to conventional bead based assays. Using this kit we obtain much more consistent data, and most importantly can use much less input sample. We have made a permanent switch to using Chromatrap for all our cell line and primary cell based assays, and fully endorse the technology". Research assistant - Dr Helen Whiteland added "What I like about the Chromatrap assay is the ease of use and quick method allowing me to analyse my data in the same day".

Source: http://www.porvair-sciences.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chromatrap® - Porvair Sciences Ltd. (2014, March 20). Demand growing for Porvair Sciences' Chromatrap ChIP assay technology. News-Medical. Retrieved on June 20, 2019 from https://www.news-medical.net/news/20140106/Demand-growing-for-Porvair-Sciences-Chromatrap-ChIP-assay-technology.aspx.

  • MLA

    Chromatrap® - Porvair Sciences Ltd. "Demand growing for Porvair Sciences' Chromatrap ChIP assay technology". News-Medical. 20 June 2019. <https://www.news-medical.net/news/20140106/Demand-growing-for-Porvair-Sciences-Chromatrap-ChIP-assay-technology.aspx>.

  • Chicago

    Chromatrap® - Porvair Sciences Ltd. "Demand growing for Porvair Sciences' Chromatrap ChIP assay technology". News-Medical. https://www.news-medical.net/news/20140106/Demand-growing-for-Porvair-Sciences-Chromatrap-ChIP-assay-technology.aspx. (accessed June 20, 2019).

  • Harvard

    Chromatrap® - Porvair Sciences Ltd. 2014. Demand growing for Porvair Sciences' Chromatrap ChIP assay technology. News-Medical, viewed 20 June 2019, https://www.news-medical.net/news/20140106/Demand-growing-for-Porvair-Sciences-Chromatrap-ChIP-assay-technology.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Porvair Sciences to improve the diagnosis and treatment of ovarian cancer